C. Ann Merrifield - May 13, 2022 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
Director
Signature
/s/ Jason Cavalier, Attorney-in-Fact for C. Ann Merrifield
Stock symbol
LYRA
Transactions as of
May 13, 2022
Transactions value $
$18,486
Form type
4
Date filed
5/17/2022, 05:35 PM
Previous filing
Nov 19, 2021
Next filing
Jun 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LYRA Common Stock Purchase $16.8K +3.5K +100% $4.81 7K May 13, 2022 Direct
transaction LYRA Common Stock Purchase $1.64K +328 +4.69% $5.00 7.33K May 16, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24 - Power of Attorney